AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 150 participants.

Also called NCT03732794

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03732794
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03732794. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-30 (actual); primary completion 2024-06-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
Acronym
ICE-AFIB
Condition
Atrial Fibrillation (AF)
Condition
Persistent Atrial Fibrillation
Condition
Longstanding Persistent Atrial Fibrillation
Intervention (Device)
AtriCure CryoICE & AtriClip LAA Exclusion
Lead sponsor
AtriCure, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03732794
Content hash
42b124a0074a7ba3a85cb8a0fabbd3573a288c0d0598e17a4250a06853997315